Ingredion (INGR) Q2 2026 Earnings Call Transcript
Ingredion (NYSE:INGR) reported Q2 2026 net sales of $1.85B (+1%) and adjusted operating income of $258M (-5%). Adjusted EPS was $2.82. Management cited Argo facility issues, Mexico currency headwinds, and rising tapioca costs. It reaffirmed 2026 adjusted EPS guidance of $10.30 to $10.90 and expects Tate & Lyle acquisition synergies of $130M run-rate by 2030.
How this was made
The 30-second read
Why it matters
Net sales grew 1% but adjusted operating income fell 5% due to manufacturing issues and FX headwinds, while management reaffirmed 2026 adjusted EPS guidance and adjusted operating income and cash flow expectations for divestitures and ongoing inflation. The Tate & Lyle deal provides a longer-dated synergy and accretion framework, but near-term trading is likely driven by Argo reliability progress and the lagged pass-through of higher tapioca costs.
Market read
This is a full earnings-call disclosure with multiple quantified guidance updates and deal-related targets, giving traders concrete inputs for near-term estimate revisions and longer-dated integration expectations.
What to watch
The tapioca root cost increase is expected to take 1 to 1.5 quarters for pass-through, so the key swing factor for near-term estimates is timing of customer pricing rather than the magnitude of the cost increase itself.
Background
The transcript covers Ingredion’s Q2 2026 performance, operational recovery at the Argo facility, raw-material inflation (tapioca), Mexico/LATAM headwinds, and progress on the pending Tate & Lyle acquisition plus the Pakistan divestiture.
Ticker impact
Ingredion reported Q2 net sales of $1.85B and adjusted EPS of $2.82, while reaffirming 2026 EPS guidance and updating operating income/cash flow assumptions.
Likely choppy trading around guidance credibility, with downside risk if Argo and Mexico demand softness persist longer than management’s pass-through timeline.
The article provides concrete Q2 results and multiple 2026 guidance components (EPS, operating income down mid-single digits, CFO $700M-$800M, capex $450M-$490M) tied to identifiable drivers (Argo issues, Mexico FX/demand, tapioca cost pass-through lag).
Market effects
Ingredient peers may see read-across on specialty solutions demand durability and on the timing of raw-material cost pass-through (tapioca).
Mexico FX and demand softness are explicitly cited as a full-year operating income headwind, which can pressure regional earnings expectations for other food ingredient suppliers with LATAM exposure.
Tate & Lyle acquisition metrics (synergies and EPS accretion target) can influence broader M&A and integration expectations in the global ingredients space.
Counterpoint
Reaffirmed full-year adjusted EPS guidance ($10.30 to $10.90) suggests the market may be over-discounting near-term margin compression if Argo normalization and specialty volume growth offset cost inflation.
Key entities
- companyIngredion Incorporated
Reported Q2 2026 results and provided updated 2026 guidance, including EPS reaffirmation and operating income/cash flow adjustments tied to Argo, Mexico FX/demand, and tapioca cost inflation.
- companyTate & Lyle
Pending acquisition expected to add $2.7B revenue post-closing, with targeted $130M run-rate synergies by 2030 and >15% adjusted EPS accretion in the first full calendar year after close.
- facilityArgo facility
Primary North American production site; exited June at normal production rates after resolving refinery issues and an April thermal event.
- asset_divestiturePakistan business (majority stake)
Majority stake sale completed, with 2026 guidance adjusted for the divestiture’s second-half operating income and cash flow impacts.
